Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
MSCI Inc. | Chairman and CEO, Director | Common Stock | 1.75M | $820M | $469.66 | Apr 25, 2024 | Direct |
MSCI Inc. | Chairman and CEO, Director | Common Stock | 327K | $154M | $469.66 | Apr 25, 2024 | By Fernandez 2007 Children's Trust |
MSCI Inc. | Chairman and CEO, Director | Common Stock | 15.4K | $7.23M | $469.66 | Apr 25, 2024 | By Daughter |
MSCI Inc. | Chairman and CEO, Director | Common Stock | 15.4K | $7.23M | $469.66 | Apr 25, 2024 | By Son |
Royalty Pharma plc | Director | Class A Ordinary Shares | 58.2K | $1.63M | $27.92 | Sep 30, 2024 | By Fernandez 2007 Children's Trust |
Royalty Pharma plc | Director | Class A Ordinary Shares | 58.2K | $1.56M | $26.80 | Jun 28, 2024 | By Fernandez 2007 Children's Trust |
Royalty Pharma plc | Director | Class A Ordinary Shares | 54K | $1.51M | $27.92 | Sep 30, 2024 | Direct |
Royalty Pharma plc | Director | Class A Ordinary Shares | 52.7K | $1.41M | $26.80 | Jun 28, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RPRX | Royalty Pharma plc | Sep 30, 2024 | 1 | $37.5K | 4 | Sep 30, 2024 | Director |
RPRX | Royalty Pharma plc | Jun 28, 2024 | 1 | $37.5K | 4 | Jun 28, 2024 | Director |
RPRX | Royalty Pharma plc | Jun 7, 2024 | 1 | $0 | 4 | Jun 10, 2024 | Director |
MSCI | MSCI Inc. | Apr 25, 2024 | 15 | $6.06M | 4 | Apr 26, 2024 | Chairman and CEO, Director |
RPRX | Royalty Pharma plc | Mar 28, 2024 | 1 | $37.5K | 4 | Apr 2, 2024 | Director |
MSCI | MSCI Inc. | Feb 5, 2024 | 4 | -$29.5M | 4 | Feb 7, 2024 | Chairman and CEO, Director |
RPRX | Royalty Pharma plc | Dec 29, 2023 | 1 | $37.5K | 4 | Dec 29, 2023 | Director |
RPRX | Royalty Pharma plc | Sep 29, 2023 | 1 | $37.5K | 4 | Oct 3, 2023 | Director |
RPRX | Royalty Pharma plc | Jun 30, 2023 | 1 | $37.5K | 4 | Jun 30, 2023 | Director |
RPRX | Royalty Pharma plc | Jun 23, 2023 | 1 | $0 | 4 | Jun 26, 2023 | Director |
RPRX | Royalty Pharma plc | Mar 31, 2023 | 1 | $37.5K | 4 | Mar 31, 2023 | Director |
MSCI | MSCI Inc. | Feb 8, 2023 | 2 | -$8.77M | 4 | Feb 10, 2023 | Chairman and CEO, Director |
RPRX | Royalty Pharma plc | Dec 30, 2022 | 1 | $37.5K | 4 | Jan 3, 2023 | Director |
RPRX | Royalty Pharma plc | Sep 30, 2022 | 1 | $37.5K | 4 | Sep 30, 2022 | Director |
RPRX | Royalty Pharma plc | Jun 30, 2022 | 1 | $37.5K | 4 | Jun 30, 2022 | Director |
RPRX | Royalty Pharma plc | Jun 24, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
RPRX | Royalty Pharma plc | Mar 31, 2022 | 1 | $37.5K | 4 | Apr 1, 2022 | Director |
RPRX | Royalty Pharma plc | Feb 24, 2022 | 1 | $1.22M | 4 | Feb 25, 2022 | Director |
MSCI | MSCI Inc. | Feb 7, 2022 | 6 | -$23.4M | 4 | Feb 9, 2022 | Chairman and CEO, Director |
RPRX | Royalty Pharma plc | Dec 31, 2021 | 1 | $37.5K | 4 | Jan 3, 2022 | Director |
RPRX | Royalty Pharma plc | Sep 30, 2021 | 1 | $37.5K | 4 | Sep 30, 2021 | Director |
RPRX | Royalty Pharma plc | Jun 30, 2021 | 1 | $37.5K | 4 | Jun 30, 2021 | Director |
RPRX | Royalty Pharma plc | Jun 25, 2021 | 1 | $0 | 4 | Jun 29, 2021 | Director |